Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-02-13FDA Approved: FLUOCINOLONE ACETONIDE TOPICAL SOLUTION USP, 0.01% — Original Application (Encube Ethicals, Inc.)
FDA approves Encube Ethicals' generic fluocinonide acetonide topical solution 0.01% (Original Application) for inflammatory and pruritic cor…
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Efficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
A completed Phase 2 trial evaluated the efficacy and potential steroid-sparing effects of DGLA cream in early childhood patients with modera…
-
CLINICAL_TRIALS research · 2019-02-05Clinical Trial Update: Study to Evaluate the Use of a Probiotic in SCORAD Reduction in Young Patients With Atopic Dermatitis [NA]
This entry reports an ongoing clinical trial sponsored by Biopolis S.L. evaluating a probiotic to reduce SCORAD in young patients with atopi…
-
FDA approval · 2019-01-30FDA Approved: DESONIDE OINTMENT, 0.05% — Original Application (Encube Ethicals, Inc.)
FDA approved Desonide Ointment 0.05% as a generic topical corticosteroid for relief of inflammatory and pruritic skin conditions; indicated …
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842. [Phase 1]
A Phase 1 drug-drug interaction study evaluated the effect of fluvoxamine or fluconazole on the pharmacokinetics and safety of PF-04965842. …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute Eczema [Phase 2]
A Phase 2 clinical trial evaluating ZL-3101 for subacute eczema has completed. The study was sponsored by Zai Lab Pty. Ltd.
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal [Phase 4]
Phase 4 study in atopic dermatitis evaluating serum and skin biopsy biomarkers in patients treated with topical corticosteroids and after wi…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM) [Phase 3]
Phase 3 trial evaluating whether 18-month levocetirizine treatment in infants with atopic dermatitis and grass pollen/house dust mite sensit…
-
CLINICAL_TRIALS withdrawal · 2019-01-17Clinical Trial Update: A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial evaluating a botanical product containing East Indian Sandalwood Oil for atopic dermatitis has been withdrawn. Spon…
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis [Phase 2]
Phase II study assessing immunogenicity and safety of MVA-BN (IMVAMUNE) smallpox vaccine in subjects with atopic dermatitis.
-
FDA approval · 2018-12-27FDA Approved: PIMECROLIMUS — Original Application (Actavis Pharma, Inc.)
FDA approves Actavis Pharma, Inc.'s original application for a generic pimecrolimus topical product. The product is indicated for the treatm…
-
CLINICAL_TRIALS trial_result · 2018-12-26Clinical Trial Update: Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial of mepolizumab in moderate to severe atopic dermatitis was terminated; results posted in 2018.
-
FDA approval · 2018-12-26FDA Approved: CLOBETASOL PROPIONATE — Original Application (AvKARE)
FDA approved AvKARE's original ANDA for clobetasol propionate topical product (generic).
-
FDA approval · 2018-12-14FDA Approved: HYDROCORTISONE VALERATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's hydrocortisone valerate as a generic topical corticosteroid under an original ANDA (ANDA211750).
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis [Phase 3]
A Phase 3 clinical trial evaluating desoximetasone (DSXS) for efficacy and safety in atopic dermatitis has completed, with results posted in…
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: An Open Label, Safety Study to Assess the Potential for Adrenal Suppression. [Phase 2]
Phase 2 open-label safety trial evaluating potential adrenal suppression risk in subjects with atopic dermatitis; study completed with resul…
-
CLINICAL_TRIALS research · 2018-12-07Clinical Trial Update: Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis [Phase 2]
Phase 2 trial investigating potential adrenal suppression after DSXS treatment in patients with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: A Randomized, Double-blinded Placebo-controlled Study to Investigate Antimicrobial Efficacy and Safety Following Topical Application of DPK-060 [Phase 1, Phase 2]
A randomized, double-blind, placebo-controlled study assessing antimicrobial efficacy and safety of topical DPK-060 in atopic dermatitis com…
-
FDA approval · 2018-11-29FDA Approved: FLUOCINONIDE — Original Application (Encube Ethicals, Inc.)
The FDA approved Encube Ethicals, Inc.'s fluocinonide topical solution 0.05% as a generic topical corticosteroid for inflammatory and prurit…
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis [Phase 3]
Phase 3 clinical study of AmorePacific's TRPV1 antagonist for atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis [Phase 1, Phase 2]
Clinical trial update for PAC-14028 cream in pediatric atopic dermatitis, reporting safety and efficacy data from Phase 1/2 completed study.
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis [Phase 2]
Phase 2 trial update on pharmacokinetics and safety of MM36 topical ointment in children with atopic dermatitis; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis [Phase 1, Phase 2]
A study evaluating the efficacy and safety of HAT01H in atopic dermatitis and eczema has completed Phase 1 and Phase 2 trials.
-
CLINICAL_TRIALS trial_result · 2018-11-06Clinical Trial Update: A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests [Phase 4]
Phase 4 trial assessing safety and sensitizing potential of HAT1 topical products using skin sensitivity patch tests in healthy and atopic d…
-
FDA approval · 2018-11-05FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Cosette Pharmaceuticals, Inc.)
The FDA approved the original application for Fluocinonide Acetonide (a generic topical corticosteroid) from Cosette Pharmaceuticals, Inc.